Light Therapy Market Analysis

Global Light Therapy Market Overview

Light Therapy Market Size was valued at USD 0.98 Billion in 2023. The Global Light Therapy industry is projected to grow from USD 1.03 Billion in 2024 to USD 1.56 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.33% during the forecast period (2024 - 2032). increasing frequency of psychological illnesses including SAD, sadness, and anxiety, as well as increasing prevalence of dermatological problems are the key market drivers enhancing the light therapy growth.

Light therapy, commonly referred to as heliotherapy or phototherapy, is a medical procedure that involves exposing a patient to artificial or comparable light. Major depressive disorders, seasonal affective disorder (SAD), and other skin diseases are the main conditions this therapy treats. Light therapy has produced notable improvements in treating skin conditions such as eczema, vitiligo, psoriasis, and acne vulgaris. Depending on the type of light, there are several kinds of light therapies, including blue light therapy, red light therapy, and white light therapy. The rising prevalence of mental health and skin disorders, as well as increased investments, product launches, research and development, and the adoption of crucial tactics by leading market competitors, are the factors driving the growth of the market under study.

A novel procedure that shows promise in reducing wrinkles, redness, acne, scars, and other aging indicators is red light therapy (RLT), also known as photobiomodulation. Compared to various topical skin treatments, this therapy is less harmful, intrusive, and abrasive. Low-wavelength red light is purportedly used in red light therapy (RLT) to treat various medical ailments and reportedly improve the appearance of the skin. The market is driven by the rising prevalence of skin diseases and the rising acceptance of non-invasive therapies. In addition, the market participants participate in numerous strategic projects, including product launches, which promote the sector's development. The prevalence of sleep disorders is significantly rising as individuals lead more sedentary lifestyles.

February 2024, The Luminia Pro line consists of advanced light treatment devices designed for therapeutic use, with expanded customisation options for different skin types and disorders.

March 2024, BioPhotas launched the “ReviveLED Pro”, this new device incorporates improved LED technology and programmable settings for personalized treatment.

In April 2023, Zerigo Health launched the Zerigo 2.0 ecosystem, a digital platform specifically developed to streamline the management and phototherapy treatment of persistent skin disorders. This platform connects healthcare systems with patients, making the process more efficient and accessible. The American Academy of Dermatology has produced guidelines that confirm the safety and effectiveness of phototherapy for treating psoriasis and eczema. Zerigo created the Zerigo Health ecosystem, which includes a portable ultraviolet B light therapy equipment operated by a smartphone application. This entire treatment suite also provides access to healthcare professionals who monitor patient adherence and offer motivational support. The Zerigo Health Phototherapy System, a light therapy device developed to address various dermatological disorders such as psoriasis and atopic dermatitis, received FDA approval in 2017.

In September 2023, Therabody unveiled their versatile LED face mask and head massager, which was well-received by the public. The innovative equipment combines vibration therapy with red and blue light. Therabody is mostly known for its extensive range of percussive therapy devices, including the popular Theragun, which was designed by chiropractor Jason Wersland. In the subsequent year, the firm diversified its product line by introducing the TheraFace Pro, a multifunctional facial gadget that offers eight different functions, including percussive massage, focused LED light treatment, and microcurrent toning. The company diversified its portfolio of hygiene goods by introducing the TheraFace Mask. Therabody integrated its percussive techniques into the face mask design, in line with its dedication to promoting wellness.

The US Food and Drug Administration (FDA) has released a draft advice for photobiomodulation (PBM) devices, also known as low-level light therapy (LLLT) devices, which are frequently used for cosmetic or dermatological purposes, such as the treatment of cold sores. While certain light-emitting devices have modest hazards for users and are covered by the agency's general wellness devices policy, other light-emitting devices may have dangers for users that are substantial enough for the agency to classify them as regulated medical devices. The FDA issued a guide to submit 510(k) applications for photobiomodulation (PBM) devices, also referred to as LLLTs. Patients receive non-heating doses of light radiation from the products, frequently for dermatological and aesthetic operations.

Light Therapy Market Trends

• Increased incidence of conditions including depression and Insomnia will accelerate market expansion of light therapy.

Depression is a common illness worldwide, impacting more than 264 million people as of 2020, according to a report published by the World Health Organization. Since 2016, mental and addictive disorders impacted over a billion people, comprising 7% of all  burden of disease as measured in disability-adjusted life years (DALYs).Also, according to the US National Institute of Mental Health (NIMH), around 52 million adults, or one in five of all people, suffered from mental illnesses as of 2019. The prevalence was higher among females (24.5%) than males (16.3%), with young adults aged 18-25 years having the highest prevalence at nearly 30%. If untreated, mental disorders and depression are estimated to contribute to economic losses of US$ 2.5-8.5 trillion ly, a figure likely to double by 2030, according to World Bank estimates. Hence, the popularity of light therapy is expected to incline massively in the future. Light therapy products are known to alleviate seasonal affective disorders (SADs) in particular, by enhancing serotonin levels.

As people increasingly lead sedentary lifestyles, sleep disorder incidences are experiencing a significant incline. The American Sleep Association forecasts that 50-70 million US adults have a sleep disorder, with chronic insomnia accounting for a tenth of overall sleep disorders. Furthermore, 37% of 20-39-year-olds report short sleep duration, while 40% of them belong to the 40-59-year-old category. ly, insomnia incidences amount to 10-30% of the  population, sometimes reaching as high as 50-60%. The consequences of insomnia are significant, such as depression, impaired work performance, work-related or motor vehicle accidents, and overall poor quality of life. Fortunately, this condition is preventable with a variety of treatment alternatives available.

Light therapy is one such approach, as it is known to correct an individual’s circadian rhythm, which is a part of the body’s internal clock that causes one to feel alert and awake during the daytime and sleepy at night. When used correctly, light therapy can encourage a circadian rhythm reset which may help improve sleep outcomes.

According to a study published by the National Center for Biotechnology Information in 2013, skin conditions contributed to nearly 2% of the total  burden of disease as measured in disability-adjusted life years (DALYs). Skin and subcutaneous disorders were the 4th leading cause of non-fatal disease burden. Dermatitis resulted in the greatest burden, costing 9.3 million DALYs.The World Health Organization noted in 2016 that the reported prevalence of psoriasis worldwide ranged between 0.09% and 11.43%, making it a serious problem. In the United States, it affects about 7.4 million people. Also, 30-33% of people with psoriasis go on to develop psoriatic arthritis, while guttate psoriasis affects 8% of the people with this condition, while plaque psoriasis comprises constitutes 80-90% of the cases. There these are the key factors which will boost market CAGR of light therapy.

Light Therapy Market Segment Insights

Light Therapy Product type Insights

The market segmentation of  Light Therapy, based on Product type, includes Light Box, Floor and Desk Lamps, Light Visor, HDST, Others . Among them, it is anticipated that the rising usage of lightboxes for SAD therapy would accelerate market segment growth over the research period. However, the dawn simulator parts are seen to be considerably more user-friendly than lightboxes and are valuable instruments for adjusting the circadian cycle.

Light Therapy application Insights

The  Light Therapy market segmentation, based on application, includes Psoriasis, Vitiligo, Eczema, Acne Vulgaris, Others. Due to the rising incidence of psoriasis, the psoriasis application market is among those that is expanding more quickly. Nearly 25%–30% of people worldwide suffer from psoriasis, which can cause joint inflammation and arthritic symptoms, fueling the market's expansion.

Light Therapy Light type Insights

The  market segments of Light Therapy, based on Light type, includes Blue Light, Red Light, White Light, Others. Due to the growing use of blue light for the treatment of skin cancer and sun damage, the blue light market is thought to be the largest of these. Additionally, the white light component is advantageous since it reduces SAD and depression-related symptoms, which promotes the expansion of the worldwide light therapy industry. Additionally, the fastest-growing sector of the worldwide industry is thought to be red light therapy, which is increasingly used to treat arthritis and joint pain.

Figure 2 Light Therapy Market, by Light type, 2023 & 2032(USD Billion)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Light Therapy End-User Insights

The Light Therapy market segmentation, based on End-User, includes Homecare Settings, Dermatology Clinics, Others. Due to the rising prevalence of dermatological problems, the dermatology clinics sector is one of these that is contributing to the growth of the worldwide market. On the other hand, the home care settings sector is promoting the growth of the light treatment industry since the equipment are inexpensive and simple to use.

News

Data from a small sham-controlled clinical experiment show that Symbyx Neuro, Symbyx Biome's red/infrared light therapy helmet, improves motor function in Parkinson's disease. Parkinson's "has historically been an untreatable, neurodegenerative disorder that usually deteriorates with no hope of treatment. These improvements outperformed a fake helmet regarding walking, tremor, upper limb, and facial expression. According to Symbyx, light treatment may lessen Parkinson's symptoms by concentrating on the cell's energy centers, the mitochondria, and the production of dopamine, an abnormally low signaling molecule in Parkinson's. Additionally, it might help nerves function and lessen pain and inflammation.​

Light Therapy Regional Insights

By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Light Therapy market accounted for USD 0.34 billion in 2021 and is expected to exhibit a significant CAGR growth during the study period. North America dominated the phototherapy equipment market with a revenue share of 43.20% in 2021. The rising number of various skin conditions such as vitiligo, psoriasis, eczema, and acne is expected to help the region dominate the phototherapy equipment market. For instance, according to the Canadian Dermatology Association, acne affects around 5.6 million people in Canada, i.e., 20% of the total population suffers from acne. Similarly, as per the latest estimates by Atopic Dermatitis in America, around 7.3% of U.S. adults suffer from eczema, while around 40% of the people suffer from moderate to severe symptoms.

Further, the major countries studied in the market report are The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3 LIGHT THERAPY MARKET SHARE BY REGION 2023 (%)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

However, the Asia-Pacific region is projected to witness the fastest growth rate of 5.55% during the forecast period. The increase in the number of births of pre-term babies and a number of people suffering from skin disorders can be accredited to the high growth rate. For instance, as per The Lancet, around 85% of preterm births occur in the late preterm period, out of which 80% occur in Asia & South-Asian regions. Moreover, according to Narayan Health Organization, out of the 15 million pre-term births ly, 1/5th of these births take place in India alone. Additionally, people in the Asia Pacific are prone to acne, which is further expected to propel the use of phototherapy equipment. For instance, according to the Derma Health Institute, acne is a common condition for people of Asian ethnicity, thereby impelling the phototherapy equipment market in this region.

Europe Light Therapy market accounts for the third-largest market share are due  to Growth of europe market of light therapy is majorly driven by increase in skin disorders, rise in patients suffering from depression, increase in prevalence of seasonal affective depression, and mood conditions. Moreover, increased urge to look beautiful cause rise in adoption of light therapies in the female population. Thus, this factor is anticipated to fuel the growth of market. Further, the Germany market of light therapy held the largest market share, and the UK market of light therapy was the fastest growing market in the European region

Light Therapy Key Market Players & Competitive Insights

Major market players are spending a lot of money on R&D to increase their product lines, which will help in the market growth of Light Therapy. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the Light Therapy industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the  Light Therapy industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, Light Therapy industry has provided medicine with some of the most significant benefits. The Light Therapy market major player such as Beurer (Germany),  Northern Light Technology (Canada),   BioPhotas (US),   Chal-Tec GmbH (Germany),   Koninklijke Philips (Netherlands)   Lucimed SA (Belgium), Lumie (UK), Verilux (US),  Nature Bright (Taiwan),  Zepter International (Switzerland)., and others are working to expand the market demand by investing in research and development activities.

Beurer GmbH is a German family-owned Mittelstand manufacturer of electrical devices for health and well-being. Originally a manufacturer of electric blankets, the company began diversifying its product line in the 1980s and now sell some 2,200 products including weighing scales, blood pressure monitors, and mobile ECG devices.

Koninklijke Philips N.V.  commonly shortened to Philips, is Dutch multinational conglomerate corporation that was founded in Eindhoven in 1891.  Philips was formerly one of the largest electronics companies in the world, but is currently focused on the area of health technology, having divested its other divisions.

Key Companies in the Light Therapy market includes

• Beurer (Germany)


• Northern Light Technology (Canada)


• BioPhotas (US)


• Chal-Tec GmbH (Germany)


• Koninklijke Philips (Netherlands)


• Lucimed SA (Belgium)


• Lumie (UK)


• Verilux (US)


• Nature Bright (Taiwan)


• Zepter International (Switzerland) 

Light Therapy Industry Developments

• June 2022 LightStim introduced its latest LED light therapy called Elipsa, a device that can be seamlessly used with BeautyHealth’s advanced HydraFacial system, Syndeo. LightStim Elipsa enhances the experience as well as treatment results.


• December 2020 Med Technologies launched a home use product ‘Omnilux Contour’. Additionally, the company launched a new online store for all its products, which was expected to help the company gain some market share during and after the COVID-19 pandemic.

Light Therapy Market Segmentation

Light Therapy Product Outlook

• Light Box


• Floor and Desk Lamps


• Light Visor


• HDST

Light Therapy Application Outlook

• Psoriasis


• Vitiligo


• Eczema


• Acne Vulgaris

Light Therapy type Outlook

• Blue Light


• Red Light


• White Light

Light Therapy End-User Outlook

• Homecare Settings


• Dermatology Clinics

Light Therapy Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America